Notice on holding the 2024 First Extraordinary General Meeting of Shareholders
Announcement on the Resignation of Non-Independent Directors and the By-election of Non-Independent Directors
Constitution of Shanghai Southern Model Biotechnology Co., Ltd. (Revised in September 2024)
Announcement on increasing the scope of business of the company and revising the “Articles of Association”
Announcement of Resolutions of the 16th Meeting of the Third Board of Directors
Nanmo Biotech: Announcement on the repurchase of the company\'s shares to reach 3% of the total share capital through centralized bidding transactions and the implementation results of the share repurchase
Nanmo Biotech: Announcement on holding the 2024 semi-annual results briefing
Announcement on the repurchase of the company\'s shares through centralized bidding transactions to reach 3% of the total share capital and the implementation results of the share repurchase
Announcement on holding the 2024 semi-annual results briefing
Nanmo Biotech: China International Finance Corporation\'s Verification Report on the Shareholders of Shanghai Nanfang Model Biotechnology Co., Ltd. requesting quotations and transfers of shares to specific institutional investors
Nanmo Biotech: Shareholder Inquiry and Transfer Results Report and Prompt Announcement of Changes in Shareholders\' Equity with 5% or More Shareholders\' Equity Changes of 1%
China International Finance Corporation Verification Report on Shareholders of Shanghai Southern Model Biotechnology Co., Ltd. requesting quotations and transfers of shares to specific institutional investors
Shareholders\' inquiry and transfer results report and indicative announcement that changes in the equity of shareholders holding 5% or more of the shares reached 1%
Shareholders\' inquiries and indicative notice on transfer pricing
China International Finance Corporation\'s inspection opinions on the qualifications of shareholders of Shanghai Southern Model Biotechnology Co., Ltd. to inquire and transfer shares to specific institutional investors
Shareholders\' inquiry and transfer plan
Nanmo Biotech Investor Relations Activity Record Form 2024-006
Haitong Securities Co., Ltd.\'s 2024 semi-annual follow-up report on the continuous supervision of Shanghai Southern Model Biotechnology Co., Ltd.
Announcement on the progress of share repurchase through centralized bidding transactions
Special Report on the Deposit and Use of Funds Raised for the Semi-Annual Year of 2024
No Data
No Data